![background](/_next/image/?url=%2Fimages%2Fbackground-teal.webp&w=1920&q=75)
About Us
![Mother and daughter](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F10%2FMother-and-daughter.png&w=3840&q=75)
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. We believe that it takes a community to build a great medicine, and that is why we are working to set the new standard for developing medicines in the field of oncology – one that revolves around collaboration, shared learning, and excellence.
Syndax’s mission is to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients by drawing on the newest scientific research and advances, collaborating with determined problem solvers, and identifying value in overlooked aspects of science.
We have a seasoned and effective executive team steeped in science, with proven expertise across a broad range of disciplines and an unwavering commitment to delivering on our mission for patients.
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Michael A. Metzger](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2FMichael-50A-2-scaled-e1702469785552.jpg&w=2048&q=75)
Michael A. Metzger
Chief Executive Officer and Director
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Luke J. Albrecht](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2F221012_Syndax_LukeAlbrect_HiRes-0217-1-scaled-e1702469647444.jpg&w=1920&q=75)
Luke J. Albrecht
General Counsel
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Steve Closter](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2024%2F03%2FSteve-Closter-Headshot-with-Updated-Background.png&w=3840&q=75)
Steve Closter
Chief Commercial Officer
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Neil Gallagher, M.D., Ph.D.](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2FNeil-Gallagher_4x-e1702469818107.png&w=3840&q=75)
Neil Gallagher, M.D., Ph.D.
President, Head of Research and Development
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Anjali Ganguli, Ph.D.](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2F221012_Syndax_AnjaliGanguli_HiRes-0161-1-scaled-e1702469559814.jpg&w=2048&q=75)
Anjali Ganguli, Ph.D.
Chief Strategy Officer
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Keith A. Goldan](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2F221012_Syndax_KeithGoldan_HiRes-9956-1-scaled-e1702469620843.jpg&w=1920&q=75)
Keith A. Goldan
Chief Financial Officer
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Kate Madigan, M.D.](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2F221012_Syndax_KateMadigan-0566-1-scaled-e1702469586668.jpg&w=1920&q=75)
Kate Madigan, M.D.
Chief Medical Officer
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Kevin McManus](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2FKevinMcManus_v2WhiteBackground-scaled-e1702469713479.jpg&w=2048&q=75)
Kevin McManus
Chief People Officer
![drop](/_next/image/?url=%2Fimages%2Fdrop%2Fdrop-small.webp&w=640&q=75)
![Peter Ordentlich, Ph.D.](/_next/image/?url=https%3A%2F%2Fcms.syndax.com%2Fwp-content%2Fuploads%2F2023%2F12%2F221012_Syndax_PeterOrdentlich_HiRes-0349-2-scaled-e1702469681564.jpg&w=2048&q=75)
Peter Ordentlich, Ph.D.
Chief Scientific Officer and Founder